Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicola Beltraminelli

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Blood|September 20, 2002
Junctional adhesion molecule-2 (JAM-2) promotes lymphocyte transendothelial migrationCaroline A Johnson-Léger, Michel Aurrand-Lions, Nicola Beltraminelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Combining radiotherapy with APO010 in cancer treatmentInge Verbrugge, Esther H J Wissink, Rogier W Rooswinkel, et al.
Leukemia Research|September 27, 2005
A Fas agonist induces high levels of apoptosis in haematological malignanciesPeter Greaney, Aimable Nahimana, Lucienne Lagopoulos, et al.
Plos One|July 30, 2021
Attenuating nicotine's effects with high affinity human anti-nicotine monoclonal antibodiesMichael D Raleigh, Nicola Beltraminelli, Stephanie Fallot, et al.
Mabs|June 22, 2010
EB66 cell line, a duck embryonic stem cell-derived substrate for the industrial production of therapeutic monoclonal antibodies with enhanced ADCC activityStéphane Olivier, Marine Jacoby, Cédric Brillon, et al.
Vaccine|May 25, 2019
Deciphering the domain specificity of C. difficile toxin neutralizing antibodiesLeah E Cole, Lu Li, Utsav Jetley, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Blood|September 20, 2002
Junctional adhesion molecule-2 (JAM-2) promotes lymphocyte transendothelial migrationCaroline A Johnson-Léger, Michel Aurrand-Lions, Nicola Beltraminelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Combining radiotherapy with APO010 in cancer treatmentInge Verbrugge, Esther H J Wissink, Rogier W Rooswinkel, et al.
Leukemia Research|September 27, 2005
A Fas agonist induces high levels of apoptosis in haematological malignanciesPeter Greaney, Aimable Nahimana, Lucienne Lagopoulos, et al.
Plos One|July 30, 2021
Attenuating nicotine's effects with high affinity human anti-nicotine monoclonal antibodiesMichael D Raleigh, Nicola Beltraminelli, Stephanie Fallot, et al.
Mabs|June 22, 2010
EB66 cell line, a duck embryonic stem cell-derived substrate for the industrial production of therapeutic monoclonal antibodies with enhanced ADCC activityStéphane Olivier, Marine Jacoby, Cédric Brillon, et al.
Vaccine|May 25, 2019
Deciphering the domain specificity of C. difficile toxin neutralizing antibodiesLeah E Cole, Lu Li, Utsav Jetley, et al.
Pageof 1